Form 4 for AEHR AEHR TEST SYSTEMS
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-23 · accession 0001654954-22-015718 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-11-23 | 2022-11-23 | AEHR | OLIPHANT LAURA | Dir | S - Sale | $27.00 | -1,901 | 12.7K | -13% | -$51.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-23 | S | D | 1,901 | $27.00 | 12,651 | I by Trust | — | — | (F1) The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 2, 2022. (F2) The amount reported includes shares subject to unvested restricted stock units. |